𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease

✍ Scribed by Watts, R. L.; Jankovic, J.; Waters, C.; Rajput, A.; Boroojerdi, B.; Rao, J.

Book ID
118050659
Publisher
Lippincott Williams and Wilkins
Year
2007
Tongue
English
Weight
249 KB
Volume
68
Category
Article
ISSN
0028-3878

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Rotigotine transdermal patch in early Pa
Rotigotine transdermal patch in early Parkinson's disease: A randomized, double-blind, controlled study versus placebo and ropinirole
✍ Nir Giladi; Babak Boroojerdi; Amos D. Korczyn; David J. Burn; Carl E. Clarke; An πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 167 KB

## Abstract Rotigotine is a new, non‐ergot dopamine agonist formulated in a transdermal delivery system. The present study was to investigate the efficacy and safety of the rotigotine transdermal patch in the treatment of early Parkinson's disease. Patients (n = 561) were randomized to rotigotine,

Double-blind, randomized, controlled tri
Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients
✍ Matthew B. Stern; Kenneth L. Marek; Joseph Friedman; Robert A. Hauser; Peter A. πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 172 KB πŸ‘ 2 views

## Abstract Rasagiline (__N__‐propargyl‐1(__R__)‐aminoindan) mesylate is a potent, selective, and irreversible monoamine oxidase‐B inhibitor. This study was designed to evaluate the safety, tolerability, and preliminary efficacy of rasagiline monotherapy in early Parkinson's disease (PD) patients n

Rotigotine effects on early morning moto
Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double-blind, randomized, placebo-controlled study (RECOVER)
✍ Claudia Trenkwalder; Bryan Kies; Monika Rudzinska; Jennifer Fine; Janos Nikl; Kr πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 752 KB

In a multinational, double-blind, placebo-controlled trial (NCT00474058), 287 subjects with Parkinson's disease (PD) and unsatisfactory early-morning motor symptom control were randomized 2:1 to receive rotigotine (2–16 mg/24 hr [n = 190]) or placebo (n = 97). Treatment was titrated to optimal dose

A randomized, double-blind trial of tran
A randomized, double-blind trial of transcranial electrostimulation in early Parkinson's disease
✍ Holly A. Shill; Sanja Obradov; Yakov Katsnelson; Ray Pizinger πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 90 KB πŸ‘ 1 views

## Abstract We studied the effects of noninvasive transcranial electrical stimulation on the motor and psychological symptoms of early Parkinson's disease. Twenty‐three subjects were treated with 10 days of placebo versus active treatment and then followed for 14 weeks. Baseline off medication Unif